降钙素基因相关肽
血管生成
内分泌学
内科学
缺血
降钙素
神经肽
后肢
血管内皮生长因子
碱性成纤维细胞生长因子
新生血管
医学
生物
生长因子
受体
血管内皮生长因子受体
作者
Toshiaki Mishima,Yoshiya Ito,Kanako Hosono,Yukio Tamura,Yasushi Uchida,Mitsuhiro Hirata,Tatsunori Suzsuki,Hideki Amano,Shintaro Kato,Yukiko Kurihara,Hiroki Kurihara,Izumi Hayashi,Masahiko Watanabe,Masataka Majima
出处
期刊:American Journal of Physiology-heart and Circulatory Physiology
[American Physical Society]
日期:2010-12-04
卷期号:300 (2): H431-H439
被引量:70
标识
DOI:10.1152/ajpheart.00466.2010
摘要
It is known that the neural system plays a fundamental role in neovascularization. A neuropeptide, calcitonin gene-related peptide (CGRP), is widely distributed in the central and peripheral neuronal systems. However, it remains to be elucidated the role of CGRP in angiogenesis during ischemia. The present study examined whether endogenous CGRP released from neuronal systems facilitates revascularization in response to ischemia using CGRP knockout mice (CGRP-/-). CGRP-/- or their wild-type littermates (CGRP+/+) were subjected to unilateral hindlimb ischemia. CGRP-/- exhibited impaired blood flow recovery from ischemia and decreased capillary density expressed in terms of the number of CD-31-positive cells in the ischemic tissues compared with CGRP+/+. In vivo microscopic studies showed that the functional capillary density in CGRP-/- was reduced. Hindlimb ischemia increased the expression of pro-CGRP mRNA and of CGRP protein in the lumbar dorsal root ganglia. Lack of CGRP decreased mRNA expression of growth factors, including CD31, vascular endothelial growth factor-A, basic fibroblast growth factor, and transforming growth factor-β, in the ischemic limb tissue. The application of CGRP enhanced the mRNA expression of CD31 and VEGF-A in human umbilical vein endothelial cells (HUVECs) and fibroblasts. Subcutaneous infusion of CGRP8-37, a CGRP antagonist, using miniosmotic pumps delayed angiogenesis and reduced the expression of proangiogenic growth factors during hindlimb ischemia. These results indicate that endogenous CGRP facilitates angiogenesis in response to ischemia. Targeting CGRP may provide a promising approach for controlling angiogenesis related to pathophysiological conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI